Showing results (361-370 of 534) with videos related to

Sort By:
Pageof 54
Blood Cancer Journal|November 25, 2025
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guideWei-Ying Jen, Curtis A Lachowiez, Jennifer Marvin-Peek, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Trevor Jamison, et al.
American Journal of Hematology|October 30, 2021
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapyKoji Sasaki, Tapan Kadia, Kebede Begna, et al.
American Journal of Hematology|January 23, 2016
Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemiaNicholas J Short, Hagop M Kantarjian, Elias J Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2020
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid LeukemiaFarhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, et al.
Infection Control and Hospital Epidemiology|February 27, 2003
A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993-1995Francisco Alvarado-Ramy, Elise M Beltrami, Louise J Short, et al.
Cancer|January 30, 2023
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemiaKoji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
American Journal of Hematology|November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expressionElias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Cancer|March 7, 2023
Association between bariatric surgery and outcomes in chronic myeloid leukemiaFadi G Haddad, Hagop M Kantarjian, Aram Bidikian, et al.
American Journal of Hematology|March 31, 2022
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitorsFadi G Haddad, Koji Sasaki, Ghayas C Issa, et al.
Pageof 54